Sitagliptin in Combination with Metformin Immediate-Release and Insulin In a 24-week placebo-controlled study of sitagliptin 100 mg as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin immediate-release and insulin (sitagliptin, N=229
Tirzepatide: What the Human Evidence Actually Shows Tirzepatides evidence base is the kind that supports an approval: large, completed, randomised Phase 3 trials with active and placebo comparators
SCFAs can affect the integrity of the intestinal mucosa, glucose and lipid metabolism, immune system, and inflammatory responses
Understanding your lab landscape before, during, and after GLP-1 therapy initiation is essential for safe, personalized care
What truly sets us apart is our ability to integrate aesthetics and wellness under one roof
If you are taking or thinking about taking a GLP-1 drug from a compounding pharmacy, you need to be careful